BBIO insider trades & Congress trades
BridgeBio Pharma, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 10 open-market insider transactions in BridgeBio Pharma, Inc. (BBIO) (0 purchases with code P and 10 sales with code S), the most recent on October 30, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 10 sales by 2 ($4.56M).
Members of Congress have disclosed 1 trades in BBIO (0 purchases, 1 sales), the latest transaction dated September 29, 2026. Congress filings can arrive up to 45 days after the trade.
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | Apuli Maricel | Chief Accounting Officer | Sell | 2,000 | $72.85 | $146K | – |
| Sep 17, 2026 | Kumar Neil | Chief Executive Officer | Sell | 8,721 | $69.01 | $602K | +0.0% |
| Sep 17, 2026 | Kumar Neil | Chief Executive Officer | Sell | 1,279 | $69.57 | $89K | +0.0% |
| Aug 19, 2026 | Kumar Neil | Chief Executive Officer | Sell | 8,100 | $83.86 | $679K | −0.2% |
| Aug 19, 2026 | Kumar Neil | Chief Executive Officer | Sell | 1,800 | $84.69 | $152K | −0.2% |
| Aug 19, 2026 | Kumar Neil | Chief Executive Officer | Sell | 100 | $85.65 | $9K | −0.2% |
| Aug 18, 2026 | Kumar Neil | Chief Executive Officer | Sell | 1,900 | $81.15 | $154K | −0.2% |
| Aug 18, 2026 | Kumar Neil | Chief Executive Officer | Sell | 17,279 | $82.21 | $1.42M | −0.2% |
| Aug 18, 2026 | Kumar Neil | Chief Executive Officer | Sell | 14,602 | $82.99 | $1.21M | −0.2% |
| Aug 18, 2026 | Kumar Neil | Chief Executive Officer | Sell | 1,199 | $83.77 | $100K | −0.2% |
Congress trades
Disclosures under the STOCK Act. Amounts are reported as ranges; some trades are made by a spouse or dependent child.
| Traded | Member | Party | Type | Amount | Disclosed | Filing |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | Gilbert Cisneros | house | Sell | $1,001 - $15,000 | Oct 12, 2026 | Source |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.